KMWM
AGN

Keudell/Morrison Wealth Management’s Allergan plc AGN Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,440
Closed -$275K – 162
2019
Q4 		$275K Sell
1,440
-69
-5% -$12.4K 0.19% 121
2019
Q3 		$254K Sell
1,509
-309
-17% -$50.3K 0.21% 122
2019
Q2 		$289K Sell
1,818
-27
-1% -$3.74K 0.25% 112
2019
Q1 		$270K Buy
+1,845
New +$267K 0.24% 109

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Keudell/Morrison Wealth Management's AGN Position: Q1 2020 in Review

Keudell/Morrison Wealth Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,440 shares — an estimated $275K sold.

Keudell/Morrison Wealth Management first reported a position in AGN in Q1 2019 and held it in 4 quarters. The position peaked at $289K in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Keudell/Morrison Wealth Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Keudell/Morrison Wealth Management sold 1,440 Allergan plc shares in Q1 2020, an estimated $275K.
  • Keudell/Morrison Wealth Management first reported a position in Allergan plc in Q1 2019 and held it in 4 quarters.
  • Keudell/Morrison Wealth Management's Allergan plc position peaked at $289K in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Keudell/Morrison Wealth Management's 13F filing for Q1 2020, filed 20 Apr 2020.